[FOR RELEASE August 4, 2016 China Biologic Reports Financial Results for the Second Quarter of 2016 --2Q16 Total Sales Up 23.4% with Non-GAAP Net Income Up 31.3% YoY in RMB terms, or Up 15.5% YoY to $91.4 Million and 23.1% YoY to $35.2 Million in USD terms, respectively --1H16 Total Sales Up 26.2% with Non-GAAP Net Income Up 30.6% YoY] []
[1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Capital Research Global Investors ** 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware 5 SOLE VOTING POWER 3,031,654 6 SHARED VOTING POWER NUMBER OF SHARES NONE BENEFICIALL Y OWNED]
[China Biologic Opens Plasma Collection Station in Hebei Province BEIJING, China – June 20, 2016 – The Company received approval to build two new plasma collection stations in Xinglong and Daming Counties, respectively, in October 2014. The new Xinglong station covers a collection territory of approximately 0.4 million people. The Company expects the new station to reach its designed annual] []
[China Biologic Opens Plasma Collection Station in Hebei Province BEIJING, China – June 20, 2016 – The Company received approval to build two new plasma collection stations in Xinglong and Daming Counties, respectively, in October 2014. The new Xinglong station covers a collection territory of approximately 0.4 million people. The Company expects the new station to reach its designed annual] []
[CUSIP No. 16938C106 1. Names of reporting persons. WP X Biologics LLC 2. Check the appropriate box if a member of a group (see instructions). ¨ x (a) 3. SEC use only 4. Source of funds (see instructions) N/A 5. ¨]
[CUSIP No. 16938C106 1. Names of reporting persons. WP X Biologics LLC 2. Check the appropriate box if a member of a group (see instructions). ¨ x (a) 3. SEC use only 4. Source of funds (see instructions) N/A 5. ¨]
[7) Registration No. 333-204761 PROSPECTUS SUPPLEMENT Issued June 2, 2016 (To Prospectus dated June 5, 2015) 2,775,000 Shares China Biologic Products, Inc. Common Stock The selling stockholders identified in this prospectus supplement are offering 2,775,000 shares of common stock. We will not receive any proceeds from the sale of shares by the selling stockholders. Our common stock is listed on]
[7) Registration No. 333-204761 PROSPECTUS SUPPLEMENT Issued June 2, 2016 (To Prospectus dated June 5, 2015) 2,775,000 Shares China Biologic Products, Inc. Common Stock The selling stockholders identified in this prospectus supplement are offering 2,775,000 shares of common stock. We will not receive any proceeds from the sale of shares by the selling stockholders. Our common stock is listed on]
